We also observed increased levels of IFN-γ mRNA expression in SSc patient carriers of IRF8 rs11117432*A when compared with the non-carriers (P = 0.03) with a trend for difference for the whole group (P = 0.11) but no difference in controls (P = 0.35) (Figure 3B). This evidence concerns the gene IRF8 and systemic sclerosis.